Onconetix logo

Onconetix

ONCO | NASDAQ
Chart Builder DCF Calculator
$2.91
-$0.29 (-9.20%)
At close: Nov 16, 2026, 4:00 PM ET
$2.95
+$0.04 (+1.37%)
After-hours: Nov 16, 2026, 7:30 PM ET
-9.20%

No price chart data available for 1D timeframe.

Rating

Updated: Nov 16, 2026
31.7
+3.0 pts
Fundamentals Weak
Market Sentiment Neutral
Moat None
Sector Rank #754/1021 (Top 74%)

Key Statistics

Market Data

Market Cap $1.04M
1D Range
2.76 3.21
52W Range
0.61 149.50

Valuation (TTM)

PE -0.03
PB 0.08
EV/EBITDA 0.48

Valuation (NTM)

Forward PE N/A
Forward PEG -0.00
Price Target $0.00
Loading financial charts...

Profile

Onconetix, Inc. operates as a biotechnology and pharmaceutical firm, committed to pioneering and bringing to market innovative treatments aimed at resolving critical health issues worldwide. The compa...

Sector Healthcare
Industry Biotechnology
Employees 2
IPO Date Feb 18, 2022
Fiscal Year January - December

Latest News

Realbotix Provides Update on Nasdaq Listing Timeline

8 days ago · businesswire.com

Realbotix Provides Update on Nasdaq Listing Timeline
Onconetix Acquisition Target Realbotix Launches Echo Humanoid Robot Line with Tabletop and Full Body Models Designed for Education, Wellness, and Social Engagement

21 days ago · globenewswire.com

Onconetix Acquisition Target Realbotix Launches Echo Humanoid Robot Line with Tabletop and Full Body Models Designed for Education, Wellness, and Social Engagement
Onconetix Announces Reverse Stock Split

21 days ago · globenewswire.com

Onconetix Announces Reverse Stock Split
Onconetix Provides Additional Strategic Bridge Financing to Realbotix LLC in Continued Support of Pending Acquisition

25 days ago · globenewswire.com

Onconetix Provides Additional Strategic Bridge Financing to Realbotix LLC in Continued Support of Pending Acquisition
Realbotix Announces Additional Draw under Bridge Loan from Onconetix

25 days ago · businesswire.com

Realbotix Announces Additional Draw under Bridge Loan from Onconetix
SRX Global Provides Shareholders with Update on Liquidation of Two Portfolio Investments and Adds an Investment in Onconetix (Nasdaq: ONCO)

2 months ago · globenewswire.com

SRX Global Provides Shareholders with Update on Liquidation of Two Portfolio Investments and Adds an Investment in Onconetix (Nasdaq: ONCO)
CORRECTED: Onconetix Provides Strategic Bridge Financing to Realbotix LLC in Support of Pending Acquisition

2 months ago · globenewswire.com

CORRECTED: Onconetix Provides Strategic Bridge Financing to Realbotix LLC in Support of Pending Acquisition
Onconetix Provides Strategic Bridge Financing to Realbotix LLC in Support of Pending Acquisition

2 months ago · globenewswire.com

Onconetix Provides Strategic Bridge Financing to Realbotix LLC in Support of Pending Acquisition
Realbotix LLC Announces Bridge Loan from Onconetix

2 months ago · businesswire.com

Realbotix LLC Announces Bridge Loan from Onconetix
Onconetix Acquisition Target Realbotix Launches Pilot with Leading European Telecommunications Company to Deploy Humanoid Robots in Live Presentations and Events

2 months ago · globenewswire.com

Onconetix Acquisition Target Realbotix Launches Pilot with Leading European Telecommunications Company to Deploy Humanoid Robots in Live Presentations and Events

Earnings

Next Earnings
Mar 11, 2027
EPS Est
Pro
Rev Est
Pro
Earnings Details ➞

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.